CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-12 | LOAR MATTHEW M Chief Financial Officer | Purchase | +250,000 | 300,000 | ||
| 2018-04-12 | LOAR MATTHEW M Chief Financial Officer | Purchase · Common Stock A Warrant (Right to Buy) | +125,000 | 125,000 | ||
| 2018-04-12 | LOAR MATTHEW M Chief Financial Officer | Purchase · Common Stock B Warrant (Right to Buy) | +125,000 | 125,000 | ||
| 2017-06-09 | Pedder Simon Director | Grant or award · Stock Option (Right to Buy) | +121,483 | 121,483 | ||
| 2017-06-09 | SANDAGE BOBBY W. JR., PHD. Director | Grant or award · Stock Option (Right to Buy) | +121,483 | 121,483 | ||
| 2017-06-09 | Reynolds Donald Rogers Director | Grant or award · Stock Option (Right to Buy) | +121,483 | 121,483 | ||
| 2017-01-12 | Schwieterman William D President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +550,000 | $0.38 | $206K | 550,000 |
| 2017-01-12 | LOAR MATTHEW M Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +350,000 | $0.38 | $131K | 350,000 |
| 2017-01-12 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +262,500 | $0.38 | $98K | 262,500 |
| 2016-12-16 | Reynolds Donald Rogers Director | Purchase | +12,700 | $0.34 | $4K | 12,700 |
| 2016-12-16 | Reynolds Donald Rogers Director | Purchase | +7,350 | $0.35 | $3K | 20,050 |
| 2016-12-16 | Reynolds Donald Rogers Director | Purchase | +9,950 | $0.36 | $4K | 30,000 |
| 2016-10-25 | SANDAGE BOBBY W PHD Director | Grant or award · Stock Option (Right to Buy) | +135,612 | 135,612 | ||
| 2016-10-25 | Reynolds Donald Rogers Director | Grant or award · Stock Option (Right to Buy) | +135,612 | 135,612 | ||
| 2016-06-01 | Pedder Simon Director | Grant or award · Stock Option (Right to Buy) | +91,564 | 91,564 | ||
| 2016-06-01 | McMahon Gerald PhD Director | Grant or award · Stock Option (Right to Purchase) | +91,564 | 91,564 | ||
| 2016-06-01 | DRISCOLL FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +91,564 | 91,564 | ||
| 2016-03-21 | Schwieterman William D President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2016-03-21 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +262,500 | 262,500 | ||
| 2016-03-21 | Schwieterman William D President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +525,000 | 525,000 |
Page 5 of 7 · 140 trades